These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3137744)

  • 1. [Possible diagnosis of Pseudomonas aeruginosa infection by an immunoenzyme method using pyoimmunogen as the antigen].
    Severtsova MK; Dubova VG; Getmanova MA; Temper RM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):63-6. PubMed ID: 3137744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoenzyme analysis method for detecting anti-Pseudomonas aeruginosa antibodies in persons inoculated with pyoimmunogen].
    Severtsova MK; Vaĭda MB; Varró R
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):55-9. PubMed ID: 3920846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of an immunoenzyme method for detecting specific antibodies to Pseudomonas aeruginosa in patients with acute and chronic lung diseases].
    Dubeĭkovskaia ZA; Savitskaia KI; Antsiferova NG; Shakhanina KL; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):53-7. PubMed ID: 6415971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of a latex agglutination method for the diagnosis of Pseudomonas aeruginosa infection].
    Aleksandrova IA; Antsiferova NG; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):10-4. PubMed ID: 3087117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice].
    Aleksandrova IA; Titova TI; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):46-50. PubMed ID: 2496541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against Pseudomonas aeruginosa infection: 2. Clinico-immunological investigations.
    Krokhina MA; Grishina IA; Panova YuM ; Terekhova RP; Severtsova MK; Yedvabnaya LS; Vaide M; Varro R; Rusanov VM; Kolker II
    Vaccine; 1985 Sep; 3(3):316-24. PubMed ID: 3933202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoenzyme method of diagnosing suppurative-septic complications due to Pseudomonas aeruginosa and Proteus].
    Bulava GV; Ermolin GA; Grigor'ev NI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):89-93. PubMed ID: 6431720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic effectiveness of erythrocyte immunoreagents made from different Pseudomonas aeruginosa antigens].
    Egizova SA; Deriabin PN; Karal'nik BV; Moroz AF; Aleksandrova IA; Aleksandrov AD; Slastikhin BA; Roshchina NV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):30-3. PubMed ID: 2129072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of a study of the safety, reactogenicity and immunologic effectiveness of pyoimmunogen in the immunization of volunteer donors].
    Krokhina MA; Grishina IA; Arkhipova NA; Zarubina EK; Edvabnaia LS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):95-8. PubMed ID: 7331614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immunoblot detection of serum antibodies in the diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Shand GH; Pedersen SS; Tilling R; Brown MR; Høiby N
    J Med Microbiol; 1988 Nov; 27(3):169-77. PubMed ID: 3143012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
    Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA; Enzersberger O; Schober-Bendixen S; Mitterer A; Mundt W; Livey I; Pabst H; Kaeser R; Eibl M; Eibl J
    Antibiot Chemother (1971); 1991; 44():143-56. PubMed ID: 1801633
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody determinations by counterimmunoelectrophoresis in the diagnosis and management of Pseudomonas aeruginosa bone and joint infections.
    Wagner DK; Yach MT; Rytel MW
    Infection; 1986; 14(3):105-7. PubMed ID: 3089938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological reaction systems using enzyme-labelled immunospecific reagents].
    Vengerov IuIu; Levi MI; Volkov DV; Sveshnikov PG; Severin ES
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):56-61. PubMed ID: 3318229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
    Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological activity of a Proteus vaccine administered to volunteers simultaneously with a pyoimmunogen and adsorbed staphylococcal anatoxin].
    Levina LA; Iurova VA; Kreĭnin LS; Kaverina KG; Dubova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):57-61. PubMed ID: 3128030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [[Vaccine development for P. aeruginosa: based on antigen cloning of clinical vaccines][].
    von Specht BU
    Zentralbl Chir; 1999; 124(4):298-302. PubMed ID: 10355084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.